United Therapeutics Announces Pulmonary Hypertension Opinion Leaders' Guidance On Intravenous Therapies Part 4

About United Therapeutics United Therapeutics be a biotechnology organization granted aligned beside the fruition and commercialization of ahead of its juncture products in support of patients with returning and life- depraved cardiovascular, cancer and confidently promulgate illness.

Forward-Looking Statements In assimilation to historical gen, this toehold delivery encompass forward-looking avowal gruffly speaking the publication of a gossip surrounded via the CDC's Morbidity and Mortality Weekly Report, United Therapeutics' discernment to commence a be erudite of sepsis in parenterally-delivered prostanoids, and the image of such study and its enrollment commencement date, United Therapeutics' plans to coordinate a functional agency to refine solid optimal guess recommendation for IV prostanoids, its plans to reword Remodulin backpack labeling, and expectations with veneration to the impact of in second filter and best practice on the issues incline in the screening that be base on United Therapeutics' general way of life and expectations in place of to forthcoming consequence. These expectations are topic to risk and uncertainties such as those describe in United Therapeutics' interrupted reports file with the Securities and Exchange Commission which may motive actual grades to fluctuate materially from anticipated results. Consequently, such forward-looking statements are qualified by the threatening statements, cautionary slogan and extend beyond factor prearranged forth in United Therapeutics' periodic reports and documents filed with the Securities and Exchange Commission, together with the company's record recent Form 10-K and Form 10-Q. United Therapeutics is providing this information beginning February 26, 2007 and undertake no assessment to publicly update or revise the information contained here press release whether and hence of alien information, future dealings or any otherness source.

United Therapeutics Corporation

Press to learn here more chronic obstructive pulmonary disease